← Leaderboards
Mingming Ning
Massachusetts General Hospital
$8,518,949
Attributed
$10,033,941
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,033,941 · 7
By mechanism
R01$6,473,657 · 3
RF1$1,795,134 · 1
R21$901,450 · 2
K23$863,700 · 1
Top collaborators
- Eng H. Lo7 shared
- Wenjun Deng2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Eng H. Lo$32,456,318
- Ken Arai$9,570,276
- Michael A Moskowitz$13,795,692
- Michael J Whalen$16,701,509
- Pouneh Khadejeh Fazeli$3,583,785
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeSignal TransductionProteomicsPlasmaFunctional DisorderPathway InteractionsInjuryCoagulation ProcessBloodAcuteSpecificityCohortCharacteristicsResponseProteinsBaseCell Culture TechniquesMass Spectrum AnalysisBlood CirculationAffectBrainEndotheliumEnrollmentPhysiological
Grant awards (26)
The Role of Red Blood Cell in Stroke-Related Hyperglycemia$422,572
R01 · FY2025 · NS
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$1,795,134
RF1 · FY2024 · NS · contact PI
The Role of Red Blood Cell in Stroke-Related Hyperglycemia$422,572
R01 · FY2024 · NS
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$367,500
R01 · FY2023 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$367,500
R01 · FY2022 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$367,500
R01 · FY2021 · NS · contact PI
Glycoproteomics in Ischemic Stroke Related Hyperglycemia$462,000
R21 · FY2020 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$367,500
R01 · FY2020 · NS · contact PI
Thrombolysis Profiles in tPA Response$380,625
R01 · FY2019 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$367,500
R01 · FY2019 · NS · contact PI
Thrombolysis Profiles in tPA Response$380,625
R01 · FY2018 · NS · contact PI
Thrombolysis Profiles in tPA Response$380,625
R01 · FY2017 · NS · contact PI
Thrombolysis Profiles in tPA Response$380,625
R01 · FY2016 · NS · contact PI
Thrombolysis Profiles in tPA Response$380,625
R01 · FY2015 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$375,649
R01 · FY2014 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$366,163
R01 · FY2013 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$379,444
R01 · FY2012 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$379,444
R01 · FY2011 · NS · contact PI
Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury$387,188
R01 · FY2010 · NS · contact PI
Proteomic Studies of MMP Profiles in Stroke Thrombolysis$172,440
K23 · FY2009 · NS · contact PI
Proteomic Studies of MMP Profiles in Stroke Thrombolysis$172,440
K23 · FY2008 · NS · contact PI
Proteomic Studies of MMP Profiles in Stroke Thrombolysis$172,940
K23 · FY2007 · NS · contact PI
Proteomic Profile of Brain Endothelial Cell in Hypoxia$237,106
R21 · FY2006 · NS · contact PI
Proteomic Studies of MMP Profiles in Stroke Thrombolysis$172,940
K23 · FY2006 · NS · contact PI
Proteomic Profile of Brain Endothelial Cell in Hypoxia$202,344
R21 · FY2005 · NS
Proteomic Studies of MMP Profiles in Stroke Thrombolysis$172,940
K23 · FY2005 · NS